NO975962L - Legemiddelpreparat som omfatter albumin som aktiv bestanddel - Google Patents

Legemiddelpreparat som omfatter albumin som aktiv bestanddel

Info

Publication number
NO975962L
NO975962L NO975962A NO975962A NO975962L NO 975962 L NO975962 L NO 975962L NO 975962 A NO975962 A NO 975962A NO 975962 A NO975962 A NO 975962A NO 975962 L NO975962 L NO 975962L
Authority
NO
Norway
Prior art keywords
albumin
present
active ingredient
treatment
pharmaceutical composition
Prior art date
Application number
NO975962A
Other languages
English (en)
Other versions
NO320601B1 (no
NO975962D0 (no
Inventor
Kazuo Tsubota
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of NO975962D0 publication Critical patent/NO975962D0/no
Publication of NO975962L publication Critical patent/NO975962L/no
Publication of NO320601B1 publication Critical patent/NO320601B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19975962A 1996-04-19 1997-12-18 Anvendelse av albumin til fremstilling av farmasoytiske preparater NO320601B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP9809096 1996-04-19
JP10686696 1996-04-26
US75294196A 1996-11-21 1996-11-21
US75292896A 1996-11-21 1996-11-21
PCT/JP1997/001329 WO1997039769A1 (en) 1996-04-19 1997-04-17 Drug composition comprising albumin as active ingredient

Publications (3)

Publication Number Publication Date
NO975962D0 NO975962D0 (no) 1997-12-18
NO975962L true NO975962L (no) 1998-02-18
NO320601B1 NO320601B1 (no) 2005-12-27

Family

ID=27468604

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975962A NO320601B1 (no) 1996-04-19 1997-12-18 Anvendelse av albumin til fremstilling av farmasoytiske preparater

Country Status (11)

Country Link
US (2) US6043213A (no)
EP (1) EP0834320B1 (no)
JP (1) JP3058920B2 (no)
KR (1) KR100455475B1 (no)
CN (1) CN1124158C (no)
AT (1) ATE274918T1 (no)
CA (1) CA2225398C (no)
DE (1) DE69730476T2 (no)
ES (1) ES2227684T3 (no)
NO (1) NO320601B1 (no)
WO (1) WO1997039769A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2373166C (en) * 1999-07-28 2009-05-19 Morinaga Milk Industry Co., Ltd. Antiulcer agent
GB0019378D0 (en) * 2000-08-07 2000-09-27 Saugstad Ola D Method
EP1254665B1 (en) * 2001-04-26 2008-01-30 R-Tech Ueno, Ltd. Use of albumin in combination with growth factors for inhibiting apoptosis
US20030211043A1 (en) * 2001-09-28 2003-11-13 Korb Donald R. Eye treatment
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
US20050202097A1 (en) * 2004-03-12 2005-09-15 Melbj Holdings, Llc, Florida Lubricant for the ocular surface
US8455016B2 (en) 2004-03-12 2013-06-04 Melbj Holdings, Llc Treatment for meibomian gland dysfunction or obstruction
US7189697B2 (en) * 2004-04-13 2007-03-13 Trustees Of Tufts College Compositions and uses of a galectin for treatment of dry eye syndrome
US20060232060A1 (en) * 2005-04-13 2006-10-19 Assignee1 Pressure sensitive packing laminate overlay form combination and method of using same
WO2007033020A2 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation for treatment of dry eye
WO2008133928A2 (en) * 2007-04-27 2008-11-06 The Gi Company, Inc. Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders
CA2724052A1 (en) * 2008-05-15 2009-11-19 R-Tech Ueno, Ltd. Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
KR101422571B1 (ko) 2009-10-13 2014-07-24 삼성전자 주식회사 받침대 및 이를 구비한 세탁기
CN102695954A (zh) * 2009-11-27 2012-09-26 株式会社·R-技术上野 用于治疗干眼和/或角膜和结膜损伤的药剂的筛选方法以及该方法制得的药物组合物
AU2013203609B2 (en) * 2009-11-27 2014-08-21 R-Tech Ueno, Ltd. Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby
JP2014501748A (ja) * 2010-12-21 2014-01-23 リコファーマ アーベー 涙代用物
ES2960598T3 (es) 2014-05-08 2024-03-05 Kiora Pharmaceuticals Gmbh Compuestos para el tratamiento de enfermedades y trastornos oftálmicos
DE102015205293A1 (de) 2015-03-24 2016-09-29 Marc Schrott Verfahren zur Herstellung von Augentropfen
EP3437628A4 (en) * 2016-04-01 2019-11-27 Biocoz Global Korea Corp. COSMETIC COMPOSITION USING ALBUMINE, HYALURONIC ACID OR COLLAGEN AS AN ACTIVE IN CELL CULTURE MEDIUM
MX2020009235A (es) 2018-03-09 2023-01-16 Kiora Pharmaceuticals Gmbh Formulacion oftalmica.
US20200030226A1 (en) 2018-07-27 2020-01-30 Johnson & Johnson Consumer Inc. Botanical and bacterial extracts displaying retinol-like activity
WO2020021477A2 (en) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions and methods for treating the eye
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
MX2023007767A (es) 2020-12-28 2023-07-07 Davol Inc Materiales hemostaticos secos en polvo reactivos que comprenden una proteina y un agente de entrelazado a base de polietilenglicol modificado multifuncional.
WO2024018452A1 (en) 2022-07-18 2024-01-25 Yeda Research And Development Co. Ltd. Albumin protein variants, production thereof and uses of same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57126422A (en) * 1981-01-29 1982-08-06 Green Cross Corp:The Stabilizing method of lysozyme pharmaceutical
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
CA1263606A (en) * 1985-05-29 1989-12-05 Jeffrey P. Gilbard Non-toxic opthalmic preparations
JPS6391331A (ja) * 1986-10-03 1988-04-22 Senjiyu Seiyaku Kk 眼科用水性組成物
IL93996A0 (en) * 1989-04-04 1991-01-31 Alcon Lab Inc Pharmaceutical composition containing a liposome
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
JPH05310592A (ja) * 1992-05-11 1993-11-22 Nichirei Corp 創傷治療剤及び医薬製剤
JPH06271478A (ja) * 1993-03-23 1994-09-27 Otsuka Pharmaceut Co Ltd ドライアイ治療剤
EP0637450A3 (en) * 1993-08-04 1995-04-05 Collagen Corp Method and composition for resuscitation of hereditary tissue.
US6013628A (en) * 1994-02-28 2000-01-11 Regents Of The University Of Minnesota Method for treating conditions of the eye using polypeptides

Also Published As

Publication number Publication date
ES2227684T3 (es) 2005-04-01
EP0834320A4 (en) 2000-11-22
WO1997039769A1 (en) 1997-10-30
NO320601B1 (no) 2005-12-27
CA2225398A1 (en) 1997-10-30
CA2225398C (en) 2008-07-15
EP0834320B1 (en) 2004-09-01
KR100455475B1 (ko) 2004-12-17
US6043213A (en) 2000-03-28
CN1124158C (zh) 2003-10-15
DE69730476T2 (de) 2005-11-17
JP3058920B2 (ja) 2000-07-04
DE69730476D1 (de) 2004-10-07
KR19990028235A (ko) 1999-04-15
CN1195296A (zh) 1998-10-07
EP0834320A1 (en) 1998-04-08
NO975962D0 (no) 1997-12-18
US6159930A (en) 2000-12-12
ATE274918T1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
NO975962D0 (no) Legemiddelpreparat som omfatter albumin som aktiv bestanddel
IL153665A0 (en) Topical pharmaceutical formulations and methods of treatment
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
ES2173287T3 (es) Composiciones oticas antibacterianas no irritantes, no sensibilizantes y no ototoxicas.
BR9708858A (pt) Formulaç o farmacêutica e processos para preparar a mesma e para tratar um disturbio em um paciente afetável por hormônio de crescimento
PT1040830E (pt) Medicamento para doencas neurodegenerativas
WO2002009702A8 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
EP1110554A4 (en) MEDICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
DK0572190T3 (da) Oftalmiske præparater indeholdende vitamin E eller en ester deraf som en aktiv ingrediens
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
PT1069902E (pt) Utilizacao de fosfolipidos na producao de um medicamento para a prevencao de adesoes
EP1074258A3 (en) Methods and compositions for treating diseases and conditions of the eye
BR0211970A (pt) Uso de bibn4096 em combinação com outras drogas antienxaqueca para o tratamento de enxaqueca
DE69736554D1 (de) Ophthalmische arzneimittelzusammenstellung
NO933140D0 (no) Legemiddel for lokal anvendelse paa oeyet for behandling avforhoeyet intraokulart trykk
ATE303132T1 (de) Ophthalmische zubereitung mit n-acetylcystein zur behandlung trockener augen
DK0979652T3 (da) Helbredende præparat til intraokulær hypertension eller glaukom
RU2008102249A (ru) Профилактический или терапевтичесский агент для корнеального /конъюнктивального заболевания
ES2170807T3 (es) Uso de prostaglandinas para la fabricacion de un medicamento para la prevencion y el tratamiento de catarata secundaria.
AU770365B2 (en) The process for manufacturing formulation of topical beta blockers with improved efficacy
WO2001028578A3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME
BR0114339A (pt) Composições farmaceuticamente aceitáveis contendo epinastina e pseudoefedrina
ES2073245T3 (es) Agentes para el tratamiento de la cornea.
AU643772B2 (en) Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use
CA2243824A1 (en) Therapeutic agent for keratoconjunctiva diseases

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees